AN ACT ESTABLISHING AN OVERDOSE PREVENTION CENTER PILOT PROGRAM.
Connecticut establishes supervised drug consumption facility pilot program to reduce overdose deaths and infectious disease transmission.
Connecticut establishes supervised drug consumption facility pilot program to reduce overdose deaths and infectious disease transmission.
SB 492 establishes a pilot program for overdose prevention centers (OPCs) in Connecticut, which are facilities where people can use pre-obtained drugs under medical supervision with access to sterile equipment and emergency services. The bill authorizes the Department of Public Health to create and operate these facilities on a trial basis to evaluate their effectiveness in reducing overdose deaths and infectious disease transmission.
Overdose deaths remain a leading cause of unintentional injury deaths in Connecticut and nationwide. OPCs, also known as supervised consumption sites, have demonstrated in international settings (Vancouver, Sydney) and U.S. pilot programs (New York, Rhode Island) that they can reduce fatal overdoses, increase treatment linkages, and decrease emergency room visits without increasing crime or drug use in surrounding areas.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.